5 Key Takeaways

• 1

  Corneal cross-linking (CXL) is effective for keratoconus across different ethnic groups and age ranges.

• 2

  The study analyzed 570 eyes from 526 patients in the UK and Saudi Arabia, focusing on post-treatment changes.

• 3

  At three years, over 80% of eyes in both cohorts showed stabilization or improvement after CXL.

• 4

  Baseline disease severity is a more significant factor than ethnicity or age in determining CXL outcomes.

• 5

  The findings support broad CXL treatment access without delaying based on demographic factors.